Search for Clinical Trial Results

Sponsored By

Gaucher Disease Type 3 - 8 Studies Found

Status Study
Recruiting Study Name: GZ/SAR402671 in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3
Condition: Gaucher Disease Type 1-Gaucher Disease Type 3
Date: 2016-07-20
Interventions: Drug: GZ402671 Other Name: Venglustat
Recruiting Study Name: The Effect of Velaglucerase Alfa (Vpriv) on Skeletal Development in Pediatric Gaucher Disease
Condition:
  • Gaucher Disease Type 1
  • Gaucher Disease Type 3

Date: 2015-07-28
Interventions: Drug: Velaglucerase alfa Enzyme replacement therapy
Completed Study Name: OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease
Condition: Gaucher Disease
Date: 2002-07-09
Interventions: Drug: OGT 918
Completed Study Name: Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease
Condition: Gaucher Disease, Type 3
Date: 2012-09-10
Interventions: Biological: velaglucerase alfa lyophilized powder, intravenous infusion, units, Every other week (EOW)
Completed Study Name: Effects of Enzyme Replacement in Gaucher's Disease
Condition: Gaucher's Disease
Date: 1999-11-03
Completed Study Name: PEG-Glucocerebrosidase for the Treatment of Gaucher Disease
Condition: Gaucher's Disease
Date: 1999-11-03
Interventions: Drug: Lysodase
Completed Study Name: Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease
Condition: Type 2 Gaucher Disease
Date: 2005-10-26
Completed Study Name: Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease
Condition: Gaucher Disease
Date: 2006-07-10
Interventions: Procedure: Blood sample